Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Immunotherapy Brain Tumor Models

Theresa Bunse, PhD

Despite a strict control of immune processes in the central nervous system (CNS), CNS immunity is off balance during autoimmune diseases such as multiple sclerosis, and in CNS tumors like gliomas or brain metastases where active immunosuppression takes place. Despite success in other solid tumors, immunotherapies such as checkpoint inhibition (CPI) have not achieved sufficient immune re-activation in brain tumors.

The focus of the team is to understand the complex mechanisms which lay behind a response or the resistance to cancer immunotherapies such as CPI, with the commitment to explore and exploit targets for improvement of clinical outcome. Previous data suggest a critical role for the myeloid compartment such as infiltrating macrophages as well as TCR repertoire and clonality, which we are currently looking at in detail to dissect microenvironmental and tumor-intrinisc determinants that shape a responsive phenotype.

Team members

  • Theresa Bunse, PhD - Team leader
  • Dennis Agardy, M.Sc - PhD student
  • Julia Gellert, MD student
  • Verena Turco - MD student

Selected Publications


to top
powered by webEdition CMS